Vitamin D deficiency in Crohn's disease and healthy controls: A prospective case-control study in the Netherlands

Journal of Crohn's and Colitis

Volumn 8, Issue 10, 2014, Pages 1267-1273

  de Bruyn, Jessica R ^a   van Heeckeren, Rosanne ^a   Ponsioen, Cyriel Y ^a   van den Brink, Gijs R ^a   Löwenberg, Mark ^a   Bredenoord, Albert J ^a   Frijstein, Gerard ^a   D'Haens, Geert R ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

25(OH)D; Crohn's disease; Inflammatory bowel disease; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; AZATHIOPRINE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; CASE CONTROL STUDY; CHEMOLUMINESCENCE; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DISEASE COURSE; ETHNICITY; FEMALE; HUMAN; IMMUNOASSAY; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OBESITY; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SUNLIGHT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; ANALOGS AND DERIVATIVES; BLOOD; BODY MASS; ETHNOLOGY; MIDDLE AGED;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84908230688     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.03.004     Document Type: Article

References (64)

1. Holick M.F. Vitamin D deficiency. N Engl J Med Jul 19 2007, 357(3):266-281.
2. Narula N., Marshall J.K. Management of inflammatory bowel disease with vitamin D: beyond bone health. J Crohns Colitis May 2012, 6(4):397-404.
3. Ali T., Lam D., Bronze M.S., Humphrey M.B. Osteoporosis in inflammatory bowel disease. Am J Med Jul 2009, 122(7):599-604.
4. Lips P. Vitamin D, deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev Aug 2001, 22(4):477-501.
5. Raman M., Milestone A.N., Walters J.R., Hart A.L., Ghosh S. Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer. Therap Adv Gastroenterol Jan 2011, 4(1):49-62.
6. Ardizzone S., Cassinotti A., Trabattoni D., Manzionna G., Rainone V., Bevilacqua M., et al. Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol Jan 2009, 22(1):63-71.
7. Boonstra A., Barrat F.J., Crain C., Heath V.L., Savelkoul H.F., O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol Nov 1 2001, 167(9):4974-4980.
8. Bours P.H., Wielders J.P., Vermeijden J.R., van de Wiel A. Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease. Osteoporos Int Nov 2011, 22(11):2857-2867.
9. Nerich V., Monnet E., Etienne A., Louafi S., Ramee C., Rican S., et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis Mar 2006, 12(3):218-226.
10. Suibhne T.N., Cox G., Healy M., O'Morain C., O'Sullivan M. Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. J Crohns Colitis Mar 2012, 6(2):182-188.
11. Ananthakrishnan A.N., Khalili H., Higuchi L.M., Bao Y., Korzenik J.R., Giovannucci E.L., et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology Mar 2012, 142(3):482-489.
12. Ananthakrishnan A.N., Cagan A., Gainer V.S., Cai T., Cheng S.C., Savova G., et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis Aug 2013, 19(9):1921-1927.
13. Farraye F.A., Nimitphong H., Stucchi A., Dendrinos K., Boulanger A.B., Vijjeswarapu A., et al. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis Oct 2011, 17(10):2116-2121.
14. Jahnsen J., Falch J.A., Mowinckel P., Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol Feb 2002, 37(2):192-199.
15. Kuwabara A., Tanaka K., Tsugawa N., Nakase H., Tsuji H., Shide K., et al. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int Jun 2009, 20(6):935-942.
16. Leslie W.D., Miller N., Rogala L., Bernstein C.N. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol Jun 2008, 103(6):1451-1459.
17. McCarthy D., Duggan P., O'Brien M., Kiely M., McCarthy J., Shanahan F., et al. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther May 1 2005, 21(9):1073-1083.
18. Siffledeen J.S., Siminoski K., Steinhart H., Greenberg G., Fedorak R.N. The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol Aug 2003, 17(8):473-478.
19. Tajika M., Matsuura A., Nakamura T., Suzuki T., Sawaki A., Kato T., et al. Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol Jun 2004, 39(6):527-533.
20. Ulitsky A., Ananthakrishnan A.N., Naik A., Skaros S., Zadvornova Y., Binion D.G., et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr May 2011, 35(3):308-316.
21. Veldman C.M., Cantorna M.T., DeLuca H.F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys Feb 15 2000, 374(2):334-338.
22. Leichtmann G.A., Bengoa J.M., Bolt M.J., Sitrin M.D. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr Sep 1991, 54(3):548-552.
23. Wiesner R.H., Kumar R., Seeman E., Go V.L. Enterohepatic physiology of 1,25-dihydroxyvitamin D3 metabolites in normal man. J Lab Clin Med Dec 1980, 96(6):1094-1100.
24. Froicu M., Cantorna M.T. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 2007, 8:5.
25. Mahon B.D., Wittke A., Weaver V., Cantorna M.T. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem Aug 1 2003, 89(5):922-932.
26. Sentongo T.A., Semaeo E.J., Stettler N., Piccoli D.A., Stallings V.A., Zemel B.S. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr Nov 2002, 76(5):1077-1081.
27. Wang S. Epidemiology of vitamin D in health and disease. Nutr Res Rev Dec 2009, 22(2):188-203.
28. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr Jul 2006, 84(1):18-28.
29. Vieth R., Bischoff-Ferrari H., Boucher B.J., Dawson-Hughes B., Garland C.F., Heaney R.P., et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr Mar 2007, 85(3):649-650.
30. Barake M., Daher R.T., Salti I., Cortas N.K., Al-Shaar L., Habib R.H., et al. 25-hydroxyvitamin D assay variations and impact on clinical decision making. J Clin Endocrinol Metab Mar 2012, 97(3):835-843.
31. Lai J.K., Lucas R.M., Banks E., Ponsonby A.L. Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J Jan 2012, 42(1):43-50.
32. Moon H.W., Cho J.H., Hur M., Song J., Oh G.Y., Park C.M., et al. Comparison of four current 25-hydroxyvitamin D assays. Clin Biochem Mar 2012, 45(4-5):326-330.
33. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr Aug 2008, 88(2):582S-586S.
34. Vicchio D., Yergey A., O'Brien K., Allen L., Ray R., Holick M. Quantification and kinetics of 25-hydroxyvitamin D3 by isotope dilution liquid chromatography/thermospray mass spectrometry. Biol Mass Spectrom Jan 1993, 22(1):53-58.
35. Krasowski M.D. Pathology consultation on vitamin D testing. Am J Clin Pathol Oct 2011, 136(4):507-514.
36. Pappa H.M., Langereis E.J., Grand R.J., Gordon C.M. Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr Oct 2011, 53(4):361-364.
37. Fu Y.T., Chatur N., Cheong-Lee C., Salh B. Hypovitaminosis D in adults with inflammatory bowel disease: potential role of ethnicity. Dig Dis Sci Aug 2012, 57(8):2144-2148.
38. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., et al. Hypovitaminosis D in medical inpatients. N Engl J Med Mar 19 1998, 338(12):777-783.
39. Glanz K., Yaroch A.L., Dancel M., Saraiya M., Crane L.A., Buller D.B., et al. Measures of sun exposure and sun protection practices for behavioral and epidemiologic research. Arch Dermatol Feb 2008, 144(2):217-222.
40. Glanz K., Gies P., O'Riordan D.L., Elliott T., Nehl E., McCarty F., et al. Validity of self-reported solar UVR exposure compared with objectively measured UVR exposure. Cancer Epidemiol Biomarkers Prev Dec 2010, 19(12):3005-3012.
41. Mitchell D.M., Henao M.P., Finkelstein J.S., Burnett-Bowie S.A. Prevalence and predictors of vitamin D deficiency in healthy adults. Endocr Pract Sep 2012, 14:1-26.
42. Pappa H.M., Gordon C.M., Saslowsky T.M., Zholudev A., Horr B., Shih M.C., et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics Nov 2006, 118(5):1950-1961.
43. Nerich V., Jantchou P., Boutron-Ruault M.C., Monnet E., Weill A., Vanbockstael V., et al. Low exposure to sunlight is a risk factor for Crohn's disease. Aliment Pharmacol Ther Apr 2011, 33(8):940-945.
44. Sonnenberg A., McCarty D.J., Jacobsen S.J. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology Jan 1991, 100(1):143-149.
45. Armitage E.L., Aldhous M.C., Anderson N., Drummond H.E., Riemersma R.A., Ghosh S., et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology Oct 2004, 127(4):1051-1057.
46. van der Mei I.A., Ponsonby A.L., Dwyer T., Blizzard L., Simmons R., Taylor B.V., et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ Aug 9 2003, 327(7410):316.
47. van der Mei I.A., Ponsonby A.L., Dwyer T., Blizzard L., Taylor B.V., Kilpatrick T., et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol May 2007, 254(5):581-590.
48. Rostand S.G. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension Aug 1997, 30(2 Pt 1):150-156.
49. Faurschou A., Beyer D.M., Schmedes A., Bogh M.K., Philipsen P.A., Wulf H.C. The relation between sunscreen layer thickness and vitamin D production after ultraviolet B exposure: a randomized clinical trial. Br J Dermatol Aug 2012, 167(2):391-395.
50. Matsuoka L.Y., Ide L., Wortsman J., MacLaughlin J.A., Holick M.F. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab Jun 1987, 64(6):1165-1168.
51. Perrett C.M., Walker S.L., O'Donovan P., Warwick J., Harwood C.A., Karran P., et al. Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol Jul 2008, 159(1):198-204.
52. Herrlinger K.R., Kreisel W., Schwab M., Schoelmerich J., Fleig W.E., Ruhl A., et al. 6-thioguanine-efficacy and safety in chronic active Crohn's disease. Aliment Pharmacol Ther Feb 15 2003, 17(4):503-508.
53. Peyrin-Biroulet L., Khosrotehrani K., Carrat F., Bouvier A.M., Chevaux J.B., Simon T., et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology Nov 2011, 141(5):1621-1628.
54. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr Sep 2000, 72(3):690-693.
55. Samenvatting en aanbevelingen. Accessed November 19,2013 at http://www.gezondheidsraadnl/sites/default/files/samenvatting200012N_0 pdf 2013.
56. Holick M.F., Biancuzzo R.M., Chen T.C., Klein E.K., Young A., Bibuld D., et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab Mar 2008, 93(3):677-681.
57. Binkley N., Krueger D., Cowgill C.S., Plum L., Lake E., Hansen K.E., et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab Jul 2004, 89(7):3152-3157.
58. Ross A.C., Taylor C.L., Yaktine A.L., Del Valle H.B. Dietary reference intakes for calcium and vitamin D 2010, The National Academies Press, Washington, D.C.
59. J.M.van den Ouweland, A.M.Beijers, P.N.Demacker, D.H.van Daal Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci May 1 2010, 878(15-16):1163-1168.
60. Carter G.D. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets Jan 2011, 12(1):19-28.
61. Carter G.D., Jones J.C. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem Jan 2009, 46(Pt 1):79-81.
62. Farrell C., Soldo J., Williams P., Herrmann M. 25-Hydroxyvitamin D testing: challenging the performance of current automated immunoassays. Clin Chem Lab Med Nov 2012, 50(11):1953-1963.
63. Hsu S.A., Soldo J., Gupta M. Evaluation of two automated immunoassays for 25-OH vitamin D: comparison against LC-MS/MS. J Steroid Biochem Mol Biol Jul 2013, 136:139-145.
64. de Koning L., Al-Turkmani M.R., Berg A.H., Shkreta A., Law T., Kellogg M.D. Variation in clinical vitamin D status by DiaSorin Liaison and LC-MS/MS in the presence of elevated 25-OH vitamin D2. Clin Chim Acta Jan 16 2013, 415:54-58.